Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prothena Corp
(NQ:
PRTA
)
21.96
+0.98 (+4.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prothena Corp
< Previous
1
2
3
4
5
6
7
Next >
PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
PRTA stock results show that Prothena Corp beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Prothena Reports Second Quarter 2024 Financial Results and Business Highlights
August 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report Second Quarter 2024 Financial Results on August 8
August 01, 2024
From
Prothena Corporation plc
Via
Business Wire
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
June 11, 2024
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday.
Via
Investor's Business Daily
Exposures
Product Safety
Demystifying Prothena Corp: Insights From 8 Analyst Reviews
March 13, 2024
Via
Benzinga
Decoding 6 Analyst Evaluations For Prothena Corp
February 16, 2024
Via
Benzinga
Prothena Corp: Q4 Earnings Insights
February 15, 2024
Via
Benzinga
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
May 28, 2024
From
Prothena Corporation plc
Via
Business Wire
PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
PRTA stock results show that Prothena Corp missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
May 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report First Quarter 2024 Financial Results on May 8
May 01, 2024
From
Prothena Corporation plc
Via
Business Wire
Earnings Scheduled For February 15, 2024
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
Earnings Outlook For Prothena Corp
February 14, 2024
Via
Benzinga
Navigating 5 Analyst Ratings For Prothena Corp
January 25, 2024
Via
Benzinga
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
April 15, 2024
From
Prothena Corporation plc
Via
Business Wire
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.
Via
Investor's Business Daily
Exposures
Product Safety
Prothena to Participate in Upcoming Healthcare Conferences
March 05, 2024
From
Prothena Corporation plc
Via
Business Wire
$100 Invested In Prothena Corp 5 Years Ago Would Be Worth This Much Today
January 22, 2024
Via
Benzinga
Demystifying Prothena Corp: Insights From 5 Analyst Reviews
January 09, 2024
Via
Benzinga
Prothena Appoints David Ford to Newly Created Chief People Officer Position
March 04, 2024
From
Prothena Corporation plc
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
February 29, 2024
Via
Benzinga
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
February 21, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
February 15, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
February 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 30, 2024
Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales
Via
Benzinga
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
January 09, 2024
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 08, 2024
Via
Benzinga
Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday
January 08, 2024
U.S. stocks traded mixed, with the Dow Jones index falling around 80 points on Monday. Shares of The Boeing Company (NYSE: BA) fell during Friday’s session after an exit door blew out of a 737 aircraft...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs
January 08, 2024
From
Prothena Corporation plc
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.